| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
108,030,000 |
| Market
Cap: |
54.46(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.4901 - $1.4 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Selecta Biosciences is a clinical-stage biopharmaceutical company. Co.'s ImmTOR® platform encapsulates rapamycin, also known as sirolimus, a Food and Drug Administration approved immunomodulator, in biodegradable nanoparticles ImmTOR is designed to induce antigen-specific immune tolerance. By combining ImmTOR with antigens of interest, Co.'s immune tolerance platform restores self-tolerance to auto-antigens in autoimmune diseases, amplify the ability of biologics (including gene therapies) and mitigate the formation of anti-drug antibodies against biologic drugs.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
1,219,316 |
1,223,316 |
1,223,316 |
1,353,316 |
| Total Buy Value |
$686,416 |
$689,063 |
$689,063 |
$838,862 |
| Total People Bought |
1 |
1 |
1 |
2 |
| Total Buy Transactions |
10 |
13 |
13 |
14 |
| Total Shares Sold |
0 |
0 |
3,637 |
15,619 |
| Total Sell Value |
$0 |
$0 |
$3,855 |
$23,149 |
| Total People Sold |
0 |
0 |
2 |
2 |
| Total Sell Transactions |
0 |
0 |
2 |
5 |
| End Date |
2024-03-03 |
2023-12-01 |
2023-06-02 |
2022-06-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Siewers David |
Chief Financial OfficerOfficer |
• – – |
2016-06-21 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
6,923 |
|
- |
|
| Springer Timothy A |
Director |
– • • |
2016-06-21 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
40,715 |
|
- |
|
| Von Andrian Ulrich |
10% Owner |
– – • |
2016-06-21 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
100,642 |
|
- |
|
| Von Andrian Ulrich |
10% Owner |
– – • |
2016-06-21 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
414,852 |
|
- |
|
| Kania Edwin M Jr |
Director |
– • • |
2016-06-21 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
31,115 |
|
- |
|
| Osage Partners, Llc |
10% Owner |
– – • |
2016-06-21 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
70,915 |
|
- |
|
| Isaly Samuel D |
Director |
– • • |
2016-06-21 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
114,802 |
|
- |
|
| Abraham David |
Chief Comp Off, GC & Corp SecO |
• – – |
2016-06-21 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
2,564 |
|
- |
|
258 Records found
|
|
Page 11 of 11 |
|
|
